Stock LDX LUMOS DIAGNOSTICS HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Lumos Diagnostics Holdings Limited

Equities

LDX

AU0000157091

Market Closed - Australian S.E.
Other stock markets
 07:10:07 26/06/2024 BST 		5-day change 1st Jan Change
0.028 AUD -12.50% Intraday chart for Lumos Diagnostics Holdings Limited -12.50% -61.64%
06-19 Lumos Diagnostics Receives $400,000 in Milestone Payment from Hologic; Shares Up 3% MT
06-04 Lumos Diagnostics Receives Second Payment Under IP Agreement; Shares Up 8% MT

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Lumos Diagnostics Receives $400,000 in Milestone Payment from Hologic; Shares Up 3%
Lumos Diagnostics Receives Second Payment Under IP Agreement; Shares Up 8%
Lumos Diagnostics' FebriDx May Help Optimize Antibiotic Use in Children with Febrile Respiratory Infections, Study Shows
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023
Lumos Diagnostics Hires Henry Schein as US Distributor for Respiratory Infection Blood Test; Shares Rise 4%
Lumos Diagnostics' Q4 Revenue Jumps 55%
Australian Shares Rise Ahead of US Inflation Data
Lumos Diagnostics Signs Development and IP Agreements with Hologic; Shares Up 24%
Lumos Signs Major Development and IP Agreements with Hologic, Inc
Lumos Diagnostics Raises AU$2.7 Million to Support US Launch of FebriDx, ViraDx; Shares Down 6%
US FDA Grants Emergency Use Authorization for Lumos Diagnostics' ViraDx
Lumos Diagnostics Holdings Limited Reports Earnings Results for the Full Year Ended June 30, 2023
Lumos Diagnostics Secures Europe, Japan Patents for Core Camera Reader
Lumos Diagnostics Expands FebriDx Market to Netherlands
Lumos Diagnostics Announces Core Camera Reader Patent Granted in Europe and Japan
Lumos Diagnostics Secures R&D Tax Rebate for Fiscal Year 2022
Lumos Diagnostics Signs Partnership with Henry Schein Medical for FebriDx Distribution; Shares Jump 8%
Lumos Diagnostics Holdings Limited Appoints Doug Ward to Board as Managing Director
Lumos Diagnostics Secures US FDA Clearance for Bacterial Respiratory Infection Test
Lumos Diagnostics Secures AU$9 Million in Funding from New Agreements With US Healthcare Company
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LDX Stock
  4. News Lumos Diagnostics Holdings Limited
  5. Other languages